Month: August 2021

On track for trial completion in the first quarter of 2022 Adial to host business update call at 11AM Eastern today CHARLOTTESVILLE, Va., Aug. 20, 2021 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, announces it has reached its full enrollment target of 290 subjects in the Company’s ONWARD™ Phase 3 trial evaluating AD04 as a therapeutic agent for the treatment of Alcohol Use Disorder (AUD) in persons with certain target genotypes related to the serotonin transporter and receptor genes. ONWARD trial completion is expected in the first quarter of 2022. William Stilley, Adial’s Chief Executive Officer, stated, “Meeting our enrollment target...

NEWPORT NEWS, Va., Aug. 20, 2021 (GLOBE NEWSWIRE) — As part of its hiring efforts, Huntington Ingalls Industries’ (NYSE: HII) Newport News Shipbuilding division will host a series of virtual events for various trainee, entry-level and experienced trades positions, including welders and pipe fitters. The next hiring event for fitters will be held Sept. 8. Newport News is offering $500 sign-on bonuses to select trades trainee and entry-level new hires, where no experience is needed, as well as $1,000 sign-on bonuses to select experienced trades new hires. Additional sign-on bonuses also are being offered to new hires with active security clearances for select trades positions. Newport News is actively hiring for fitters, welders, pipe fitters, deck electricians, sheet metal workers, marine painters, blasters, insulators, outside...

ELK GROVE VILLAGE, Ill., Aug. 20, 2021 (GLOBE NEWSWIRE) — SigmaTron International, Inc. (NASDAQ: SGMA), an electronic manufacturing services company, today announced that Linda K Frauendorfer Chief Financial Officer (“CFO”) of SigmaTron International, Inc. plans to retire after a 27-year career as CFO on October 31, 2021. Ms. Frauendorfer will remain active full-time at SigmaTron International, Inc. until a successor is named and throughout the transition. She will remain a director of the Company. The search for her successor will start immediately and Ms. Frauendorfer will actively participate in the selection process. Commenting on her decision to retire from full time employment, Ms. Frauendorfer stated that she looks forward to continuing to work with the Company as a director, using her 30 years of experience to support the...

SAN JOSE, Calif., Aug. 20, 2021 (GLOBE NEWSWIRE) — Synaptics® Incorporated (Nasdaq: SYNA) today announced its participation in two upcoming investor conferences.Satish Ganesan, SVP & Chief Strategy Officer and Dean Butler, CFO will be presenting at the Rosenblatt Securities Technology Summit: The Age of AI Scaling on Tuesday, August 24, 2021 at 11:00AM PT.  For more information or to participate in the webcast please visit https://www.rblt.com/tech2021Dean Butler, CFO will be presenting at the BMO 2021 Technology Summit on Wednesday, August 25, 2021 at 11:00AM PT. To view the webcast or access a replay please visit https://bmo.qumucloud.com/view/2021-tech-synapticsAbout Synaptics Incorporated: Synaptics (Nasdaq: SYNA) is changing the way humans engage with connected devices and data, engineering exceptional experiences...

SSG BidCo A/S issues subsequent bonds of EUR 7.8 million SSG BidCo A/S (the “Company”) has successfully placed subsequent bonds in an aggregate volume of EUR 7,800,000, to be issued under the framework of the Company’s outstanding senior secured bonds with ISIN SE0013234325 (the “Bonds”). The subsequent bonds will be issued in two subsequent issues comprising of a EUR 5,700,000 tranche (“First Subsequent Bond Issue”) and a EUR 2,100,000 tranche (“Second Subsequent Bond Issue”), with the proceeds from the bond issues to be used towards partially financing two acquisitions. Following the subsequent bond issues, the outstanding volume under the Bonds will increase to EUR 57,800,000. The Bonds carry a floating rate interest of EURIBOR 3m + 6.00 per cent and will fall due on 21 October 2024. The subsequent bonds will be issued at a price of...

CHARLOTTESVILLE, Va., Aug. 20, 2021 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, will host a conference call at 11:00 A.M. Eastern Time today, August 20, 2021 to provide a clinical update and discuss the latest business developments. The conference call will be available via telephone by dialing toll free 844-369-8770 for U.S. callers or +1 862-298-0840 for international callers. A webcast of the call may be accessed at https://www.webcaster4.com/Webcast/Page/2463/42538 or on the Company’s website at https://ir.adialpharma.com/. An audio replay of the call will be available through September 3, 2021 and can be accessed by dialing 877-481-4010...